Abstract
Left ventricular assist devices are widely available for end stage heart failure patients as a destination therapy or as a bridge to transplantation. Hypertension is a well-established risk factor for renal disease and stroke in the absence of a left ventricular assist device. There is increasing evidence that hypertension also contributes to various adverse outcomes including stroke, aortic insufficiency, and thromboembolic events in left ventricular device patients. The accurate measurement of blood pressure as well as the recognition and management of hypertension in patients with left ventricular assist devices is essential for optimizing device function, end organ perfusion, and for reducing the likelihood of adverse events. As clinical experience with left ventricular assist devices increases, blood pressure goals as well as methods to measure blood pressure in continuous flow left ventricular device patients have been further defined.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wasson LT, Yuzefpolskaya M, Wakabayashi M, et al. Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular device support. Heart Fail Rev. 2015;20:317–22.
Saeed O, Jermyn J, Kargoli F, et al. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail. 2015;8:551–6.
Lampert BCC, Ecker C, Weaver S. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. Ann Thorac Surg. 2014;97:139–46.
Kamdar F, Boyle A, Liao K, et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009;28(4):352–9.
Slaughter MS, Pagani FD, Rogers JG. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4S):S1–39.
Tromp TR, de Jonge N, Joles JA. Left ventricular assist devices: a kidney’s perspective. Heart Fail Rev. 2015;20(4):519–32.
Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014;33(6):555–64.
Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112–20.
Teuteberg JJ, Slaughter MS. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3(10):818–28.
Jorde UP, Uriel N, Nahumi N, et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail. 2014;7(2):310–9.
Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in LVAD supported patients. Circ Heart Fail. 2010;3(6):668–74.
Patil NP, Mohite PN, Sabashnikov A. Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation? Eur J Cardiothorac Surg. 2015;49(3):788–94.
Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23–34.
Nassif ME, Tibrewala A, Raymer DS, et al. Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke. J Heart Lung Transplant. 2015;34(4):503–8.
Wilson SR, Givertz MM, Stewarrt GC, et al. Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol. 2009;54(18):1647–59.
Smith E, Franzwa J. Chronic outpatient management of patients with left ventricular assist device. J Thorac Dis. 2015;7(12):2112–24.
Bennett M, Roberts C, Dordunoo D, et al. Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2010;29(5):593–4.
Woldendorp K, Gupta S, Lai J, et al. A novel method of blood pressure measurement in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2014;33(11):1183–6.
Lanier GM, Orlanes K, Hayashi Y, et al. Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail. 2013;6:1005–12.
Willey JZ, Boehme AK, Castagna F, et al. Hypertension and stroke in patients with left ventricular assist devices (LVADs). Curr Hypertens Rep. 2016;18(2):12.
Colombo PC, Lanier GM, Orlanes K, et al. Usefulness of a standard automated blood pressure monitor in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015;34(12):1633–5.
Bennett MK, Adatya S. Blood pressure management in mechanical circulatory support. J Thorac Dis. 2015;7(12):2125–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bennett, M.K., Smith, E.M. (2018). Management of Hypertension after Ventricular Assist Device Implant. In: Desai, C., Cotts, W., Lerma, E., Rudnick, M. (eds) Ventricular-Assist Devices and Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-74657-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-74657-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74656-2
Online ISBN: 978-3-319-74657-9
eBook Packages: MedicineMedicine (R0)